Home Cart Sign in  
Chemical Structure| 701232-20-4 Chemical Structure| 701232-20-4

Structure of T863
CAS No.: 701232-20-4

Chemical Structure| 701232-20-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

T863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells.

Synonyms: DGAT-3

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of T863

CAS No. :701232-20-4
Formula : C22H26N4O3
M.W : 394.47
SMILES Code : O=C(O)C[C@H]1CC[C@H](C2=CC=C(C3=NC4=C(N)N=CN=C4OC3(C)C)C=C2)CC1
Synonyms :
DGAT-3
MDL No. :MFCD11977270
InChI Key :FUIYMYNYUHVDPT-UHFFFAOYSA-N
Pubchem ID :9865421

Safety of T863

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
SUM159 cells 10 µM 30 minutes To study the effect of T863 on lipid droplet formation Nat Commun. 2023 May 29;14(1):3100
Mouse embryonic fibroblasts (D1D2KO MEF) 15 µM 24 hours To validate TgDGAT as a target for T863, showing severe morphological alterations and absence of lipid droplets. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00347-18
Human foreskin fibroblasts (HFF) 1-40 µM 24 hours To evaluate the effect of T863 on Toxoplasma replication, showing significant inhibition even at low concentrations. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00347-18
HEK293-DGAT1 cells 122 nM (IC50) 4 hours To evaluate the effect of T863 on inhibiting DGAT1 activity at the cellular level, results showed that T863 dose-dependently inhibited TAG formation. J Biol Chem. 2011 Dec 2;286(48):41838-41851
Rat hepatic stellate cells 20 µM 6 days To study the effect of T863 on TAG metabolism in rat HSCs, results showed that T863 significantly reduced TAG levels, indicating that DGAT1 plays a key role in the rapid TAG synthesis during rat HSC activation. J Lipid Res. 2016 Jul;57(7):1162-74
Hepatic stellate cells (HSCs) 20 µM 6 days To investigate the role of DGAT1 in the formation of newly synthesized TAGs during HSC activation, results showed that T863 inhibited the formation of new TAGs, especially PUFA-enriched TAG species. J Lipid Res. 2016 Jul;57(7):1162-74
3T3-L1 preadipocytes 50 µM 7 days Significantly reduced lipid accumulation in 3T3-L1 adipocytes without affecting cell proliferation Nutrients. 2024 Apr 2;16(7):1036.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Diet-induced obese (DIO) mouse model Oral 30 mg/kg 15 consecutive days (once daily for days 1–7, twice daily for days 8–14, and a single dose on the morning of day 15) To evaluate the effects of T863 on body weight, insulin sensitivity, and serum lipids in DIO mice, results showed that T863 caused weight loss, improved insulin sensitivity, and reduced serum lipids. J Biol Chem. 2011 Dec 2;286(48):41838-41851

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.68mL

2.54mL

1.27mL

25.35mL

5.07mL

2.54mL

References

 

Historical Records

Categories